Company profilePrivate / Non-listed

Alhavi Pharmaceutical Company

Alhavi Pharmaceutical Company is a private Tehran-based drug manufacturer established in 1968 as Parke-Davis and renamed in 1982. It produces more than 80 pharmaceutical products, including oral solid and liquid dosage forms, pediatric medicines and supplements. Its Tehran factory and broad therapeutic portfolio make it relevant to domestic medicine supply, pharmaceutical-input vendors and healthcare distributors.

ListingPrivate / Non-listed
ExportLow
VerificationBasic
ConfidenceHigh
Updated20/07/2026
OPERATING PROFILE

Operations & footprint

Products and services

Alhavi Pharmaceutical Company manufactures pharmaceutical products in dosage forms including tablets, capsules, syrups, elixirs, suspensions, drops, and pediatric medicines. Its operations are linked to domestic drug supply, pharmacy distribution, child-health products, common therapeutic categories, imported pharmaceutical inputs, quality systems, and regulated healthcare manufacturing.

Operations and assets

Alhavi operates a pharmaceutical factory on the Karaj Special Road in Tehran and produces tablets, capsules, syrups, elixirs, suspensions and drops. The company stated that it had more than 500 employees as of October 2023.

Geographic footprint

Tehran, Iran.

CORPORATE STRUCTURE

Ownership & group structure

Ownership

Privately held.

Reported scale

Employees: More than 500 employees as of October 2023.

Investor Lens

Commercial and investment relevance

Alhavi is relevant for investors assessing Iran's private pharmaceutical manufacturing base, domestic drug supply resilience, pediatric medicine demand, quality-system maturity, and dependence on imported active ingredients and excipients. It can support analysis of medicine shortages, pharmacy-channel supply, contract manufacturing potential, and regulated healthcare demand. Due diligence should verify ownership, current licenses, GMP status, product registrations, raw-material sourcing, distributor relationships, factory utilization, export activity, and exposure to pricing regulation. The company is a potential manufacturing, distribution and input-supply counterparty for oral medicines, pediatric formulations and supplements serving Iran’s healthcare market.

DECISION RISKS

Constraints, risk & compliance

Key risks and constraints

Manufacturing continuity depends on reliable access to pharmaceutical ingredients and other production inputs. Its broad regulated medicine portfolio also requires sustained product-quality and compliance management.

LOCAL COMPANY ACCESS

Need more than a public profile?

Ask Hormuz to investigate, verify or act locally around Alhavi Pharmaceutical Company. Tell us exactly what you need.

Contact the companyVerify local presenceArrange a site visitRequest pricingCheck capacitySpeak with salesConfirm specific informationCover an exhibition
Open a Desk request No service is preselected.
Related context

Connected Intelligence

Relevant geography, industry, market and execution context for this profile.

Common questions

Frequently asked questions

Direct answers to the questions most likely to arise when reviewing this profile.

What does Alhavi Pharmaceutical Company manufacture?

Alhavi manufactures more than 80 pharmaceutical products, including tablets, capsules, syrups, elixirs, suspensions and drops, across therapeutic categories such as antibiotics, cardiovascular care, diabetes, respiratory care and pediatric medicine.

Where is Alhavi Pharmaceutical Company located?

Its administrative office is in Shahrak-e Gharb, Tehran, and its factory is located at Kilometer 12 of the Karaj Special Road in Tehran, Iran.

When was Alhavi Pharmaceutical Company founded?

The company was established in May 1968 as Parke-Davis and was renamed Alhavi in 1982.

Is Alhavi Pharmaceutical Company publicly listed?

Alhavi Pharmaceutical Company is privately held.